In Austria, the research & development by business enterprise, pharmaceutical industry in current ppp $ stands at 597.13 million, reflecting an increase of 162.64 million (37.4%) compared to 2020.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Austria
No matching regions
Similar regions to Austria
Business R&D pharmaceutical in current PPP $
More indicators for Austria
Government R&D in security as % of government support
0.1%
-0.01%
(2021)
Higher-education-finacing R&D financed by general university in local currency
19,572.37M
+2,020.17M
(2021)
R&D financed by rest of the world in local currency
23,925.50M
+1,142.33M
(2022)
Government R&D financed by rest of the world in local currency
893.92M
+42.59M
(2021)
Business R&D financed by rest of the world in local currency
19,659.92M
+1,314.42M
(2021)
Non-profit R&D growth rate
2.78%
+7.47%
(2022)
Austria Business R&D pharmaceutical in current PPP $ between 1998 and 2021
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2021 | 597.13M | +162.64M |
| 2020 | 434.49M | +51.53M |
| 2019 | 382.96M | +5.40M |
| 2018 | 377.56M | -23.25M |
| 2017 | 400.81M | -0.65M |
| 2016 | 401.46M | +33.46M |
| 2015 | 368.00M | -8.18M |
| 2014 | 376.18M | +19.04M |
| 2013 | 357.14M | +63.35M |
| 2012 | 293.79M | +88.95M |
| 2011 | 204.84M | +6.19M |
| 2010 | 198.65M | -29.53M |
| 2009 | 228.18M | -68.17M |
| 2008 | 296.35M | -26.38M |
| 2007 | 322.73M | +0.45M |
| 2006 | 322.28M | +52.56M |
| 2005 | 269.72M | +82.23M |
| 2004 | 187.48M | +27.68M |
| 2003 | 159.80M | +1.06M |
| 2002 | 158.74M | +6.42M |
| 2001 | 152.33M | +2.74M |
| 2000 | 149.59M | +10.99M |
| 1999 | 138.60M | +6.74M |
| 1998 | 131.87M |